Sandoz Incorporated has recalled 11,680 bottles of Triamterene and Hydrochlorothiazide (75 mg/50 mg), a prescription medication used to treat high blood pressure and fluid retention. The recall was initiated because the tablets may be cross-contaminated with traces of other substances, including the blood pressure medication Lisinopril, as well as Mannitol, Iron, Calcium, and Phosphorous. These 500-count bottles were distributed nationwide across the United States and Puerto Rico.
The presence of unintended ingredients like Lisinopril or various minerals poses a risk of unexpected side effects or drug interactions, particularly for patients who may have sensitivities or specific medical conditions related to those substances.
Healthcare provider consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.